CliffBio
small molecule

FERRISELTZ

FERRIC AMMONIUM CITRATE

Loss of exclusivity—loss of exclusivity
CompanyOtsuka Pharmaceutical →See this company's full patent-cliff portfolio

Drug detail

Brand nameFERRISELTZ
Active ingredientFERRIC AMMONIUM CITRATE
Strength600MG/PACKET
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1997
Marketing statusDISCN

More from Otsuka Pharmaceutical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.